Alcohol and health: an evolving relationship with a consistent risk for cancer mortality in the United States and the Americas Authors: Francisco Gallardo-Vera, Saul A. Beltran-Ontiveros, Jose L. Rochin-Teran, Daniel Diaz Published: 2026 In a timely analysis, Jani and colleagues used data from the Global Burden of Disease study 2023 (GBD 2023) to describe the increasing burden of alcohol-attributable cancer mortality in the United States (US).1 Their results showed that cancer deaths due to alcohol doubled from 11,361 deaths in 1990 to 23,126 in 2023, with increasing trends across most cancer types, particularly liver and colorectal, and a disproportionately high burden on males aged 55 and older. Despite the overall decline in cancer mortality, the study revealed that alcohol’s contribution to cancer deaths exhibited sex-specific patterns, with an upward trend in males and a modest decline in females,1 a pattern likely mirrored in other high-consumption countries. This divergence suggests that progress in cancer control is being systematically undermined by pervasive alcohol consumption, particularly among older populations, where cumulative lifetime exposure manifests as malignancy.2 Such results indicate a public health failure that demands attention. The results force us to confront the uncomfortable truth that resonates across the Americas and globally: society has normalized the consumption of a Group 1 carcinogen,3 while simultaneously investing billions in cancer treatment and prevention. Over the years, the scientific narrative on alcohol and health has evolved. Initially, the prevailing idea was that moderate alcohol consumption, particularly of red wine, provided cardiovascular protection, which influenced public perception. However, in 2018, a GBD study concluded that the theoretical minimum risk exposure level (TMREL), representing the level of consumption that minimizes health loss from alcohol, was zero standard drinks per day. This challenged the long-held “J-curve” hypothesis, which suggested protective effects at low consumption levels.4 Nevertheless, a subsequent GBD study, published in 2022, revealed a more nuanced picture. The TMREL varied by age and geography, with values ranging from 0 to 0.603 standard drinks per day among younger individuals aged 15–39 years and from 0.114 to 1.87 among adults aged 40 and older.5 Consequently, policy guidelines should consider differential alcohol consumption levels according to age and geography, as well as their respective diseases and injury rates.5 To further expand the discussion, a recent publication based on the Burden of Proof analytical framework, which quantifies the strength of evidence linking risk factors to health outcomes, systematically re-evaluated dose-response relationships between alcohol consumption and 20 health outcomes.6 This global analysis confirmed that alcohol consumption is associated with an increased risk for ten cancer types, including breast, colorectal, esophageal, laryngeal, liver, pancreatic, prostate, and stomach. The strongest evidence was found for pharyngeal cancer, where alcohol consumption was associated with risk increase of at least 105%.6 While a universally applicable threshold for alcohol consumption that maximizes health for all is still lacking, any potential benefit must be weighed against the well-established harmful effects on most health outcomes, including an increased cancer risk even at very low levels of consumption. The increasing burden of alcohol-attributable cancer deaths is a regional and global concern, especially since consumption habits are changing in low- and middle-income countries, where cancer surveillance systems are often underdeveloped. The American Society of Clinical Oncology has also recognized alcohol as a major oncologic risk factor, and has called for increased public education and research.7 Global initiatives, such as the WHO's SAFER framework, provide evidence-based strategies for reducing alcohol-related harm. The challenges documented in the US are not unique and represent a growing crisis that demands urgent attention from policymakers, clinicians, and researchers throughout the Americas and beyond. The evolving evidence on the harmful health effects of alcohol consumption contrasts sharply with the social normalization of drinking, which remains deeply rooted in culture despite its well-documented carcinogenicity.8 Furthermore, public awareness of the risk associated with alcohol remains dangerously low across the Americas. Only 45% of American adults recognize alcohol as a cancer risk factor, compared to 89% who recognize tobacco as such.9 These disparities mirror those observed across countries in the Americas, where alcohol policies, taxation, and cultural norms vary widely. While the US Surgeon General's 2025 advisory recommending cancer risk warning labels on alcoholic beverages is a critical first step, it must be accompanied by comprehensive strategies including taxation, marketing restrictions, and healthcare-based screening and counseling.10 Public health guidance should be population-specific, with younger populations being advised to avoid alcohol entirely, and interventions should be prioritized for young males, who constitute the majority of those consuming harmful amounts.5 As the scientific narrative on alcohol has evolved from one of potential benefit to one of unequivocal harm, particularly concerning cancer and younger populations, public health policy must evolve accordingly to reflect the totality of evidence. Contributors FG-V, SAB-O, JLR-T, and DD conceptualization, design, and writing—original draft. SAB-O, JLR-T writing—review & editing. DD was responsible for the decision to submit the manuscript. Declaration on generative AI use The authors used the online application Rubriq Premium from American Journal Experts (https://rubriq.com accessed August 16, 2026) to translate the original manuscript from Spanish to English. The software DeepL Write Pro was used to proofread and correct the English. After using these tools, the corresponding authors reviewed and edited the content as needed and take full responsibility for the published article’s content. Declaration of interests The authors declare no conflict of interest.